SynthesisFrontiers in pharmacology2025
Facilitators for establishing a home-based medicine reverse logistic system in low- and middle-income countries - a scoping review.
Synthesis in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Policy to Practice: Community Pharmacists' Self-Reported Counseling Role in Pharmaceutical Waste Management.Healthcare (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Methods: We did a scoping review to identify the key facilitators that help the initiation and establishment of a Medicine Reverse Logistics (MRL) system for the collection of unused medicines from households. Google Scholar and PubMed were the databases searched. A qualitative synthesis of included studies was performed. Themes and subthemes were identified. The keywords used were medicines, drugs, reverse logistics, homes, houses, and households. Results: The awareness level of the various stakeholders, the sharing of responsibilities among stakeholders, incentives to stakeholders, political will and legal framework, and the utilization of logistics managerial capabilities of pharmaceutical companies were identified as key facilitators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.